A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...

The announcement came in the build-up to an R&D presentation to investors that will be held in New York later today ... come under pressure. Sanofi CEO Paul Hudson All eyes are now on today ...

Robert is currently chief digital officer at the cruise line firm Viking Cruises and will join Sanofi on 15th June. His brief is to drive Sanofi’s digital, data and technology strategy ...

French healthcare company Sanofi has decided to halt work on its once praised breast cancer medication amcenestrant after a second failed clinical trial. A possible new coronavirus vaccine ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

To combat this, allergy medication Allegra created Allegra Airways, a website designed to help find and map real-time routes ...

Sanofi has returned with 300 million euros ($326 million) to set up a more permanent radioligand project. The new entity, which will operate under the Orano Med brand, will be focused on ...

For its “Allegra Airways” campaign, the allergy medication brand used real-time pollen and air pollution data to find pockets ...

Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare business, in a deal that could yield billions of dollars for the French ...

Oct 10 (Reuters) - Denali Therapeutics (DNLI.O), opens new tab said on Thursday its partner Sanofi (SASY.PA), opens new tab has discontinued a mid-stage study testing their experimental drug to ...

“We understand the concerns parents face during RSV season, and we are dedicated to providing new solutions to protect all babies,” said Delphine Lansac, General Manager of Vaccines at Sanofi.

Oct 10 (Reuters) - Sanofi (SASY.PA), opens new tab is closing in on a deal to sell its consumer health unit for about 15 billion euros ($16.4 billion) to U.S. private equity firm Clayton Dubilier ...